,
Consistency Both collagen and glutathione work gradually
The precise timeline based on clinical trial tracking: Weeks 1-3: Mild symptoms beginning, most patients adapting to medication Weeks 4-8: Peak side effect period highest nausea, GI symptoms at their worst Weeks 9-12: Rapid improvement, most GI symptoms resolving Weeks 13-24: Minimal symptoms for most, discontinuation rate drops to under 2% Weeks 25-48: Essentially no side effects for 85%+, focus shifts to weight maintenance According to research published in the New England Journal of Medicine on GLP-1 agonists, this pattern is consistent across the entire class of incretin-based therapies
[10,11] Only FDA-approved peptides (GLP-1 agonists, tesamorelin, oxytocin, desmopressin) have rigorous long-term safety data in humans
Setria L-Glutathione Reduced supports healthy detoxification and antioxidant function
GHK-Cu: A tripeptide (glycyl-L-histidyl-L-lysine) capable of binding copper ions, forming a bioactive copper-peptide complex